Effect of BG00012 on Lymphocyte Subsets and Immunoglobulins in Subjects With Relapsing Remitting Multiple Sclerosis (RRMS).
Completed · Phase 3
Conditions studied: Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis
In brief
The primary objective of the study is to evaluate the effect of BG00012 on lymphocyte subset counts during the first year of treatment in subjects with relapsing-remitting multiple sclerosis (RRMS). A secondary objective is to evaluate the pharmacodynamic effect on absolute lymphocyte counts (ALCs) and immunoglobulins (Igs) during the first year of treatment.
Key facts
- Study ID
- NCT02525874
- Run by
- Biogen
- People needed
- 218
- Starts
- 2015-08-11
- Expected to finish
- 2018-04-23
- Last updated by the study team
- 2019-06-27
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Research Site — Gilbert, Arizona, United States
- Research Site — Long Beach, California, United States
- Research Site — Ocala, Florida, United States
- Research Site — Oldsmar, Florida, United States
- Research Site — Tampa, Florida, United States
- Research Site — Tampa, Florida, United States
- Research Site — Atlanta, Georgia, United States
- Research Site — Overland Park, Kansas, United States
- Research Site — Baltimore, Maryland, United States
- Research Site — Traverse City, Michigan, United States
- Research Site — Raleigh, North Carolina, United States
- Research Site — Spartanburg, South Carolina, United States
- Research Site — San Antonio, Texas, United States
- Research Site — Salt Lake City, Utah, United States
- Research Site — Tacoma, Washington, United States
- Research Site — La Louvière, Hainaut, Belgium
- Research Site — Bruges, West-Vlaanderen, Belgium
- Research Site — Brasschaat, Belgium
- Research Site — Plaven, Bulgaria
- Research Site — Pleven, Bulgaria
- Research Site — Sofia, Bulgaria
- Research Site — Sofia, Bulgaria
- Research Site — Sofia, Bulgaria
- Research Site — Kuwait City, Kuwait
- Research Site — Kaunas, Lithuania
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.